Editas Medicine, Inc.
EDIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $166 | $139 | $139 | $132 |
| Short-Term Investments | $0 | $40 | $82 | $138 |
| Receivables | $8 | $1 | $1 | $16 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $3 | $3 |
| Total Curr. Assets | $177 | $183 | $225 | $289 |
| Property Plant & Equip (Net) | $22 | $24 | $35 | $47 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $4 | $4 | $5 |
| Total NC Assets | $25 | $28 | $39 | $52 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $202 | $211 | $264 | $342 |
| Liabilities | – | – | – | – |
| Payables | $3 | $7 | $5 | $5 |
| Short-Term Debt | $6 | $6 | $13 | $15 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $54 | $5 | $7 | $11 |
| Other Curr. Liab. | -$2 | $48 | $47 | $46 |
| Total Curr. Liab. | $62 | $66 | $73 | $77 |
| LT Debt | $14 | $15 | $18 | $20 |
| Deferred Rev, NC | $0 | $106 | $104 | $107 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $113 | $5 | $6 | $3 |
| Total NC Liab. | $127 | $125 | $128 | $130 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $21 | $31 | $35 |
| Total Liabilities | $188 | $191 | $201 | $207 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,623 | -$1,598 | -$1,545 | -$1,468 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,636 | $1,617 | $1,607 | $1,602 |
| Total Equity | $13 | $19 | $62 | $134 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $202 | $211 | $264 | $342 |
| Net Debt | -$146 | -$117 | -$108 | -$97 |